FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
19/03/2026
Voltar para busca
Dado oficial do USPTO
ELORA.
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
10
Data de depósito
04/04/2024
Data de registro
19/08/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/08/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
AU
Examinador
BLAKESLEE, RICHARD A
Unidade examinadora
N50
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the wording "ELORA." in stylized font.
Titulares e representantes
Titulares
OncoRes Medical Pty Ltd
Representantes
Thomas M. Joseph OGC Law, LLC
Classificação técnica
Classes Nice
Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Tissue sampling devices for medical usemedical specimen containers for breast tissue; medical apparatus and instruments for use in breast cancer diagnostic surgery and breast cancer tumor removal surgery procedures; medical probes; probes for medical purposes; medical testing apparatusintraoperative imaging technology devices for use in breast cancer surgery; medical diagnostic apparatus for diagnosing breast cancer; medical imaging apparatus; medical diagnostic testing apparatus for diagnosing breast cancer; test probes for medical use; testing probes for medical diagnostic purposes; testing probes for medical purposes; apparatus for medical useoptical coherence tomography probes and micro-elastography probes for mapping and for identifying breast cancer; apparatus for medical analysisoptical coherence tomography probes and micro-elastography probes for mapping and for identifying breast cancer; apparatus for medical diagnosisoptical coherence tomography probes and micro-elastography probes for mapping and for identifying breast cancer; apparatus for medical diagnostic purposesoptical coherence tomography probes and micro-elastography probes for mapping and for identifying breast cancer; medical apparatus for diagnostic purposesapparatus for performing optical coherence tomography and micro-elastography for mapping and for identifying breast cancer; diagnostic apparatus for medical purposeshandheld combination optical coherence tomography and micro-elastography probe; diagnostic imaging apparatus for medical usean optical coherence tomography and micro-elastography apparatus for mapping and for identifying breast cancer; medical probes connected to micro-processing apparatus for medical diagnosis; apparatus for analyzing images for medical usean optical coherence tomography and micro-elastography imaging apparatus; apparatus for medical image formationnamely an optical coherence tomography and micro-elastography imaging device
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
28/02/2026
FIMP
FINAL DISPOSITION PROCESSED
28/02/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
19/11/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/11/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/11/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/11/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
24/10/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/10/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/10/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/09/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
19/08/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
19/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/07/2025
PUBO
PUBLISHED FOR OPPOSITION
01/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/06/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/05/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/05/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
28/05/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/05/2025
GNFR
FINAL REFUSAL E-MAILED
05/05/2025
CNFR
FINAL REFUSAL WRITTEN
05/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/05/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/05/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/05/2025
ATRV
ATTORNEY REVIEW COMPLETED
30/04/2025
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
24/01/2025
RFNT
REFUSAL PROCESSED BY IB
23/11/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/11/2024
RFRR
REFUSAL PROCESSED BY MPU
04/11/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/10/2024
CNRT
NON-FINAL ACTION WRITTEN
29/10/2024
DOCK
ASSIGNED TO EXAMINER
17/10/2024
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
10/08/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/06/2024
MAFR
APPLICATION FILING RECEIPT MAILED
14/05/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/05/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/05/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ELORA. ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.